| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |